FLT3 and acute myeloid leukemia: We also demonstrate that the anti-leukemic efficacy of the tyrosine kinase inhibitor A-419259 is dependent on inhibition of myeloid Src-family kinases as well as Flt3 in the context of Flt3-ITD+ AML.